|
PARP9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.191100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.576200E-03 |
| Normal-vs-Stage2 |
1.886100E-02 |
| Normal-vs-Stage3 |
2.486500E-02 |
| Normal-vs-Stage4 |
7.068200E-01 |
| Stage1-vs-Stage2 |
1.819350E-01 |
| Stage1-vs-Stage3 |
6.457200E-01 |
| Stage1-vs-Stage4 |
1.083770E-01 |
| Stage2-vs-Stage3 |
3.285600E-01 |
| Stage2-vs-Stage4 |
6.044200E-02 |
| Stage3-vs-Stage4 |
9.035800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.198500E-03 |
| Normal-vs-AfricanAmerican |
2.503700E-03 |
| Normal-vs-Asian |
1.617230E-01 |
| Caucasian-vs-AfricanAmerican |
4.383200E-01 |
| Caucasian-vs-Asian |
2.690400E-01 |
| AfricanAmerican-vs-Asian |
4.100200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.476500E-03 |
| Normal-vs-Female |
1.846540E-04 |
| Male-vs-Female |
5.774100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.430420E-01 |
| Normal-vs-Extreme_Weight |
1.372030E-02 |
| Normal-vs-Obese |
9.676200E-03 |
| Normal-vs-Extreme_Obese |
8.659200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.095200E-01 |
| Normal_Weight-vs-Obese |
3.363000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.203200E-01 |
| Extreme_Weight-vs-Obese |
6.546200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.959000E-01 |
| Obese-vs-Extreme_Obese |
2.506600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.723220E-03 |
| Normal-vs-Age(41-60Yrs) |
7.70410000000554E-05 |
| Normal-vs-Age(61-80Yrs) |
1.448050E-02 |
| Normal-vs-Age(81-100Yrs) |
6.042000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.740800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.483590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.498100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.034200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.807700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.092600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.400000E-04 |
| Normal-VS-Type2 PRCC |
1.463990E-01 |
| Normal-VS-KIRP CIMP |
1.377470E-03 |
| Normal-VS-Unclassified PRCC |
6.702500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.273900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.222000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.347400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.042640E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.730500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.942000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.923500E-02 |
| Normal-vs-N1 |
1.942090E-02 |
| Normal-vs-N2 |
8.983000E-01 |
| N0-vs-N1 |
3.712200E-01 |
| N0-vs-N2 |
6.220200E-01 |
| N1-vs-N2 |
4.029400E-01 |
|
|
